- Home
- LMND vs ACLX Comparison
LMND vs ACLX Comparison
Compare LMND & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMND
- ACLX
- Stock Information
- Founded
- LMND 2015
- ACLX 2015
- Country
- LMND United States
- ACLX United States
- Employees
- LMND N/A
- ACLX N/A
- Industry
- LMND Property-Casualty Insurers
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- LMND Finance
- ACLX Health Care
- Exchange
- LMND Nasdaq
- ACLX Nasdaq
- Market Cap
- LMND 3.9B
- ACLX 4.4B
- IPO Year
- LMND 2020
- ACLX 2022
- Fundamental
- Price
- LMND $53.46
- ACLX $87.94
- Analyst Decision
- LMND Hold
- ACLX Strong Buy
- Analyst Count
- LMND 12
- ACLX 12
- Target Price
- LMND $38.33
- ACLX $114.75
- AVG Volume (30 Days)
- LMND 2.5M
- ACLX 511.7K
- Earning Date
- LMND 10-29-2025
- ACLX 11-06-2025
- Dividend Yield
- LMND N/A
- ACLX N/A
- EPS Growth
- LMND N/A
- ACLX N/A
- EPS
- LMND N/A
- ACLX N/A
- Revenue
- LMND $600,700,000.00
- ACLX $56,979,000.00
- Revenue This Year
- LMND $38.28
- ACLX N/A
- Revenue Next Year
- LMND $62.22
- ACLX $210.71
- P/E Ratio
- LMND N/A
- ACLX N/A
- Revenue Growth
- LMND 27.51
- ACLX N/A
- 52 Week Low
- LMND $15.27
- ACLX $47.86
- 52 Week High
- LMND $62.00
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- LMND 49.79
- ACLX 72.27
- Support Level
- LMND $52.00
- ACLX $83.33
- Resistance Level
- LMND $58.44
- ACLX $89.41
- Average True Range (ATR)
- LMND 3.57
- ACLX 2.94
- MACD
- LMND -0.26
- ACLX 0.64
- Stochastic Oscillator
- LMND 32.79
- ACLX 85.95
About LMND Lemonade Inc.
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.